Brawn Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.95 M
- Company Age 34 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 175.80 Cr
- Satisfied Charges ₹ 305.68 Cr
- Revenue Growth 18.58%
- Profit Growth -7.31%
- Ebitda 21.86%
- Net Worth 20.47%
- Total Assets 15.51%
About Brawn Laboratories
Brawn Laboratories Limited (BLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 27 March 1990 and has a history of 34 years and ten months. Its registered office is in Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.95 M.
The company currently has active open charges totaling ₹175.80 Cr. The company has closed loans amounting to ₹305.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Brij Gupta, Subhash Chander, and Ankit Goyal serve as directors at the Company.
Company Details
-
Location
Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73200DL1990PLC039653
-
Company No.
039653
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
27 Mar 1990
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Brawn Laboratories Limited offer?
Brawn Laboratories Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Pain Balm & Ointments, Sexual Wellness Products, Female Hygiene Products & Test Kits, Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Lip Cosmetics, Ayurvedic Pain Relief Oil, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Brawn Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brij Gupta
|
Director | 23-Apr-2003 | Current |
|
Subhash Chander
|
Director | 12-Jul-2019 | Current |
|
Ankit Goyal
|
Director | 16-Mar-2023 | Current |
Financial Performance of Brawn Laboratories.
Brawn Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.58% increase. The company also saw a slight decrease in profitability, with a 7.31% decrease in profit. The company's net worth Soared by an impressive increase of 20.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brawn Laboratories?
In 2023, Brawn Laboratories had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Brawn Cosmetics And Herbals Private LimitedBrij Gupta is a mutual person
-
Brawn Biotech LimitedBrij Gupta and Subhash Chander are mutual person
-
Lucid Healthcare Private LimitedSubhash Chander is a mutual person
Charges (Loans)
₹175.80 Cr
₹305.68 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 100.00 Cr
- Hdfc Bank Limited : 54.80 Cr
- Others : 21.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2023 | Citi Bank N.A. | ₹50.00 Cr | Open |
| 03 Mar 2023 | Others | ₹21.00 Cr | Open |
| 03 Jun 2022 | Hdfc Bank Limited | ₹54.80 Cr | Open |
| 03 Mar 2022 | Citi Bank N.A. | ₹50.00 Cr | Open |
| 03 Jun 2022 | Hdfc Bank Limited | ₹10.00 Cr | Satisfied |
How Many Employees Work at Brawn Laboratories?
Brawn Laboratories has a workforce of 444 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brawn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brawn Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
